A64 BRONCHOPULMONARY DYSPLASIA: Study Design: Phase Ii Safety And Efficacy Of Inhaled Tissue Plasminogen Activator (activase) For The Treatment Of Acute Pediatric Plastic Bronchitis

Methods: This is a multi-center, open-label study of children (5-16 years old) with pathological evidence of fibrin PB that present with an acute exacerbation requiring hospitalization. Prior to study drug administration, lab and pulmonary function tests (PFT) will be performed and pulse oximetry an...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 195
Main Authors Stringer, K A, Schumacher, K R, Caruthers, R L, Nasr, S Z, Myers, J L
Format Journal Article
LanguageEnglish
Published New York American Thoracic Society 01.01.2017
Subjects
Bronchitis
FDA approval
Lung diseases
Pediatrics
Urine
Online AccessGet full text

Cover

More Information
Summary:Methods: This is a multi-center, open-label study of children (5-16 years old) with pathological evidence of fibrin PB that present with an acute exacerbation requiring hospitalization. Prior to study drug administration, lab and pulmonary function tests (PFT) will be performed and pulse oximetry and a chest x-ray acquired (Figure).
ISSN:1073-449X
1535-4970